Does optimal SDMA and in-range urine creatinine make reduced clearance or urine concentration a less likely explanation for elevated TMAO?

TMAO is produced when gut microbial trimethylamine is oxidized by hepatic flavin-containing monooxygenases, then is eliminated predominantly in urine. Consequently, interpretation of an elevated result depends critically on whether it reflects circulating TMAO accumulation, a concentrated spot urine specimen, or increased total urinary excretion.

Renal clearance and SDMA

• Human mass-balance studies indicate that >90% (up to ~95%) of TMAO is recovered renally, largely unchanged. In 124 individuals spanning normal kidney function, CKD, and hemodialysis, TMAO clearance approximated measured GFR, with fractional excretion of 105% ± 32%.
• Plasma TMAO increased as measured GFR declined (r²=0.388; p<0.001), supporting reduced filtration as a biologically credible cause of elevated circulating TMAO.
• An optimal SDMA directionally weighs against substantial filtration impairment: SDMA is predominantly renally excreted and correlated strongly with measured GFR in a small adult study (approximately r=−0.84). However, SDMA thresholds are assay-dependent, and a single optimal result cannot exclude clinically meaningful reduction in GFR or establish that clearance is not the principal contributor to elevated TMAO.

Urine concentration

• If the elevated TMAO measurement is from a spot urine sample, low urine volume can raise its measured concentration without raising total TMAO excretion. An in-range urine creatinine therefore makes extreme concentration or dilution a less compelling sole explanation.
• Urine creatinine is nevertheless an indirect dilution marker, influenced by age, sex, muscle mass, diet, renal function, and spot-sample variability. Urine osmolality more directly measures particle concentration; specific gravity is a practical alternative. Creatinine-adjusted TMAO and, when important, standardized repeat or 24-hour urine sampling better distinguish concentrated urine from increased excretion.

Bottom line

• Renal elimination is central to TMAO handling. Optimal SDMA and in-range urine creatinine plausibly reduce support for, but do not rule out, reduced renal clearance or urine concentration as the main explanation; interpretation should be tied to specimen type, kidney-function assessment, and direct urine-concentration measures.